Insider Activity: Immunomedics (IMMU)

Chief quality officer makes $71,000 buy and fund adds 1.5 million shares. Bryan Ball, Chief Quality Officer at Immunomedics (IMMU), bought 5,000 shares, paying around $71,000 to do so. This doubles his stake, following a similarly-sized buy back in June. Besides insider buying by officers, a number of funds have been accumulating shares as well, […]